Q2 2026 saw revenue in line with expectations, improved margins, and strong cash flow, despite year-over-year declines in net sales. Guidance for 2026 net sales and adjusted EPS was reiterated, with ongoing execution of growth and capital allocation strategies.Original document: DENTSPLY SIRONA Inc…
Dental products company Dentsply Sirona NASDAQ:XRAYwill be reporting results this Thursday after market hours. Here’s what investors should know.Dentsply Sirona beat analysts’ revenue expectations last quarter, reporting revenues of $880 million, flat year on year. It was a satisfactory quarter for…
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.Shareholders should contact the firm immed…
CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") NASDAQ:XRAY today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial r…
This milestone reflects PDS Health’s continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients.CHARLOTTE, N.C., July 01, 2026 (GLOBE NEWSWIRE) -- PDS Health® and Dentspl…
